Announced

Completed

Highland Capital Management and Coatue led a $235m funding round in Caris Life Sciences.

Synopsis

Investment firms Highland Capital Management and Coatue led a $235m funding round in Caris Life Sciences, an innovator in molecular science, with participation from T. Rowe Price Associates, OrbiMed, Millennium Management, Neuberger Berman, ClearBridge Investments, First Light Asset Management and other undisclosed investors. "This financing represents the first significant external equity investment in Caris. We are tremendously proud to partner with a diverse and high-quality syndicate of leading investors with deep domain knowledge in healthcare and technology," Brian J. Brille, Caris Vice Chairman.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Highland Capital Management and Coatue led a $235m funding round in Caris Life Sciences.